Skip to main content

Month: September 2021

Nemaura Medical Launches Beta Version of Its Metabolic Health Program

MiBoKo, a noninvasive glucose sensor utilizing AI mobile application, addresses a substantial multibillion-dollar market opportunity in healthcare LOUGHBOROUGH, England, Sept. 29, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or “the Company”), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the beta launch of MiBoKo, a new metabolic health program utilizing a noninvasive glucose sensor along with an AI mobile application. Dr. Faz Chowdhury, Nemaura’s Chief Executive Officer, will discuss MiBoKo in more detail during his corporate presentation scheduled for today, September 29, 2021 at 11:10 a.m. ET during the Benzinga Healthcare Small Cap Conference. Investors can access this...

Continue reading

Transcontinental Inc. Announces the Renewal of Its Normal Course Issuer Bid Plan

MONTRÉAL, Sept. 29, 2021 (GLOBE NEWSWIRE) — Transcontinental Inc. (TSX: TCL.A TCL.B) has been authorized to purchase for cancellation on the open market, between October 1st, 2021 and September 30, 2022, up to 1,000,000 of its Class A Subordinate Voting Shares and up to 190,300 of its Class B Shares, representing approximately 1.37% of the 73,111,944 issued and outstanding Class A Subordinate Voting Shares and of the 13,913,226 issued and outstanding Class B Shares as of September 17, 2021. The average daily trading volume on the Toronto Stock Exchange of Class A Subordinate Voting Shares for the past six months was 175,745 and the average daily trading volume on the Toronto Stock Exchange of Class B Shares for the past six months was 392. In accordance with the Toronto Stock Exchange requirements, a maximum daily purchase of the...

Continue reading

Loop Media Studios Launches First Audio Original With “Asia Pop40” Podcast

AVAILABLE NOW ON SPOTIFY, THE SHOW EXPANDS THE REACH OF LOOP MEDIA’S INTERNATIONALLY SYNDICATED WEEKLY RADIO PROGRAM Glendale, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Loop Media Studios, a division of Loop Media, Inc. (“Loop Media” or the “Company”) (OTC: LPTV), a leading multichannel streaming platform that provides curated music videos and branded entertainment channels for businesses and consumers, announced today the launch of the Company’s first audio-only offering, the “Asia Pop40” podcast. Loop Media Studios is Loop Media’s division responsible for content creation, curation and distribution.   The Asia Pop40 podcast reaches audiences worldwide on Spotify and features the top 10 songs each week in Asia that appear on Loop Media’s syndicated Asia Pop40 radio program, which is aired in more than...

Continue reading

Reliq Health Technologies, Inc. to Present at Lytham Partners Fall 2021 Investor Conference

HAMILTON, Ontario, Sept. 29, 2021 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it will participate in the Lytham Partners Fall 2021 Investor Conference from October 5-7. Reliq’s CEO, Dr. Lisa Crossley, will deliver the company’s latest investor presentation and engage in a fireside chat session on Tuesday, October 5, 2021 at 1:15pm ET. “We look forward to sharing the most recent updates on our rapidly growing business with investors at this year’s Lytham Partners Fall 2021 Investor Conference,” said Dr. Lisa Crossley, CEO at Reliq Health. A webcast of the presentation will be available on the...

Continue reading

Newtek Business Services Corp.’s Board of Directors’ Elects Two New Board Members

BOCA RATON, Fla., Sept. 29, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp. (the “Company”) (Nasdaq: NEWT), an internally managed business development company (“BDC”), today announced that its board of directors (the “Board”) has elected two new directors to the Board, Fernando Perez-Hickman and Halli Razon-Feingold, increasing the Board to seven (7) directors. The Board will now be comprised of four (4) independent directors and three (3) interested directors, as such term is defined under Section 2(a)(19) of the Investment Company Act of 1940 (the “1940 Act”). Mr. Perez-Hickman is an experienced executive with a proven track record in management, mergers & acquisitions, and value creation at financial services businesses. Mr. Perez-Hickman previously served as Vice Chairman, Director of Corporate Strategy and member...

Continue reading

Feel Foods Ltd. Completes Canpac Share Distribution to Shareholders and Adds Senior Advisor

VANCOUVER, British Columbia, Sept. 29, 2021 (GLOBE NEWSWIRE) — FEEL FOODS LTD. (the “Company” or “Feel Foods”) (CSE: “FEEL”) (OTC: “FLLLF”) announces it has completed the distribution of 15,000,000 common shares of Canpac Investments Corp. (“Canpac”) on a pro rata basis, to its shareholders of record on September 15th, 2021, pursuant to the asset purchase agreement for the sale of its Langley 5.5 acre greenhouse lands (see press release dated August 19th 2021). Canpac is a privately held investment company focused on health sciences, technology, and infrastructure. Pursuant to the Agreement, Canpac purchased the property for consideration of $1,500,000 payable in the form of the issuance of 15,000,000 common shares at a deemed price of $0.10 per share. Furthermore, Canpac has agreed to assume $912,517 in the Company’s current debt...

Continue reading

Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society

Data from two different studies benchmark Duet’s proprietary bifunctional oligonucleotides against immune checkpoint inhibitors (“Checkpoint Inhibitors”) in lymphoma and prostate tumor models in mice Studies indicate Duet’s bifunctional oligonucleotides — CpG-STAT3siRNA (DUET-01) and CpG-STAT3ASO (DUET-02) — can expand reach and efficacy of cancer immunotherapies beyond the current standard-of-care treatments NEW YORK, Sept. 29, 2021 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, today announced the release of preclinical data being presented at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society. Alan Horsager, Ph.D., President and Chief Executive Officer of...

Continue reading

Flora Growth Corp. (NASDAQ: FLGC) Ideally Positioned as Colombia Makes Cannabis Progress

NEW YORK, Sept. 29, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Flora Growth Corp. (NASDAQ: FLGC) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Latin America, Not US, Spearheading Advancements in Global Cannabis Markets,” please visit: https://nnw.fm/2cRGl When Democrats took control of Capitol Hill during the elections in November 2020, there was growing optimism that federal legalization of cannabis was in the cards for Americans. Nine months into the new administration, progress has been slow in the United States. Latin American (LATAM) countries, on the other hand, have moved forward with new laws...

Continue reading

Newtek Business Services Corp. Forecasts Full Year 2021 Net Investment Income of $0.80 per Share and Adjusted Net Investment Income of $3.40 per Share

Forecasts First Quarter 2022 Dividend of $0.65 per Share Reaffirms Annual 2021 Dividend Forecast of $3.15 per Share BOCA RATON, Fla., Sept. 29, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp. (the “Company”), (Nasdaq: NEWT), an internally managed business development company (“BDC”), today provided forecasts for its net investment income (“NII”) and adjusted net investment income (“ANII”) for the full year 2021, as well as for its first quarter 2022 dividend. The Company forecasts full year 2021 NII of $0.80 per share and ANII of $3.401 per share for 2021. In addition, the Company forecasts a first quarter 2022 dividend of $0.652 per share. The Company also reaffirmed its annual 2021 dividend forecast of $3.15 per share, which would indicate a dividend forecast of $1.05 per share in the fourth quarter of 2021. The Company...

Continue reading

Medolife Rx Files Bi-Annual Report With Ministry of Environment in the Dominican Republic, Details Reservation Expansion and Exceeds Regulatory Expectations

BURBANK, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that it has completed a bi-annual filing with the Ministry of Environment (MOE) of the Dominican Republic (DR), which detailed the expansion of its scorpion reservation and exceeded the expectations of the regulatory body. The MOE expressed further interest in the Company’s flagship product, Escozine®, which has recently renewed its registration in the DR as a natural alternative medicine for oncological treatments. The bi-annual filing is a requirement of the agreement between the MOE and Medolife. It is intended to communicate updates...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.